A Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Chemotherapy and Androgen Pathway Inhibitors
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 25 May 2017
At a glance
- Drugs Carfilzomib (Primary) ; Aciclovir; Dexamethasone; Paracetamol
- Indications Prostate cancer
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 19 May 2017 Planned End Date changed from 1 Apr 2018 to 1 Apr 2019.
- 19 May 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Apr 2018.